Vimarsana
Biggest News Aggregation in the World

Eric Weisblum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Weisblum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Weisblum Today - Breaking & Trending Today

Silo Pharma Announces Positive Results from Study for - Vimarsana News

Silo Pharma Announces Positive Results from Study for

The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse in patients with...

Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying - Alzamend Neuro (NASDAQ:ALZN), Anitra (AMEX:AZTR) - Vimarsana News

Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying - Alzamend Neuro (NASDAQ:ALZN), Anitra (AMEX:AZTR)

The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD - Vimarsana News

Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD

All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024 -- Silo Pharma, Inc. , a developmental...

Silo Pharma Completes Successful Dose-Ranging Study of - Vimarsana News

Silo Pharma Completes Successful Dose-Ranging Study of

All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024...

Silo Pharma's ketamine implant for fibromyalgia shows promise - Vimarsana News

Silo Pharma's ketamine implant for fibromyalgia shows promise

Silo Pharma’s dissolvable ketamine implant, initially targeting fibromyalgia and chronic pain, has seen success in early research.